172 related articles for article (PubMed ID: 18491963)
21. Voriconazole in the treatment of aspergillosis, scedosporiosis and other invasive fungal infections in children.
Walsh TJ; Lutsar I; Driscoll T; Dupont B; Roden M; Ghahramani P; Hodges M; Groll AH; Perfect JR
Pediatr Infect Dis J; 2002 Mar; 21(3):240-8. PubMed ID: 12005089
[TBL] [Abstract][Full Text] [Related]
22. Efficacy and safety of voriconazole in the treatment of acute invasive aspergillosis.
Denning DW; Ribaud P; Milpied N; Caillot D; Herbrecht R; Thiel E; Haas A; Ruhnke M; Lode H
Clin Infect Dis; 2002 Mar; 34(5):563-71. PubMed ID: 11807679
[TBL] [Abstract][Full Text] [Related]
23. Multifocal periostitis as a complication of chronic use of voriconazole in a lung transplant recipient.
Tedja R; El-Sherief A; Olbrych T; Gordon S
Transpl Infect Dis; 2013 Aug; 15(4):424-9. PubMed ID: 23663268
[TBL] [Abstract][Full Text] [Related]
24. The effect of therapeutic drug monitoring on safety and efficacy of voriconazole in invasive fungal infections: a randomized controlled trial.
Park WB; Kim NH; Kim KH; Lee SH; Nam WS; Yoon SH; Song KH; Choe PG; Kim NJ; Jang IJ; Oh MD; Yu KS
Clin Infect Dis; 2012 Oct; 55(8):1080-7. PubMed ID: 22761409
[TBL] [Abstract][Full Text] [Related]
25. Fluoride excess and periostitis in transplant patients receiving long-term voriconazole therapy.
Wermers RA; Cooper K; Razonable RR; Deziel PJ; Whitford GM; Kremers WK; Moyer TP
Clin Infect Dis; 2011 Mar; 52(5):604-11. PubMed ID: 21239842
[TBL] [Abstract][Full Text] [Related]
26. Voriconazole-a new therapeutic agent with an extended spectrum of antifungal activity.
Donnelly JP; De Pauw BE
Clin Microbiol Infect; 2004 Mar; 10 Suppl 1():107-17. PubMed ID: 14748807
[TBL] [Abstract][Full Text] [Related]
27. Multifocal nodular periostitis associated with prolonged voriconazole therapy in a lung transplant recipient.
Ayub A; Kenney CV; McKiernan FE
J Clin Rheumatol; 2011 Mar; 17(2):73-5. PubMed ID: 21169844
[TBL] [Abstract][Full Text] [Related]
28. Case collection study of the safety of AmBisome in association with voriconazole in the treatment of patients with invasive fungal infection.
Askari E; Jarque I; Nicolás Franco S; Cáceres Agra JJ
Rev Esp Quimioter; 2010 Dec; 23(4):210-2. PubMed ID: 21191561
[No Abstract] [Full Text] [Related]
29. Voriconazole-induced phototoxicity masquerading as chronic graft-versus-host disease of the skin in allogeneic hematopoietic cell transplant recipients.
Patel AR; Turner ML; Baird K; Gea-Banacloche J; Mitchell S; Pavletic SZ; Wise B; Cowen EW
Biol Blood Marrow Transplant; 2009 Mar; 15(3):370-6. PubMed ID: 19203729
[TBL] [Abstract][Full Text] [Related]
30. Two cases of severe phototoxic reactions related to long-term outpatient treatment with voriconazole.
Vandecasteele SJ; Van Wijngaerden E; Peetermans WE
Eur J Clin Microbiol Infect Dis; 2004 Aug; 23(8):656-7. PubMed ID: 15248093
[No Abstract] [Full Text] [Related]
31. Muco-cutaneous retinoid-effects and facial erythema related to the novel triazole antifungal agent voriconazole.
Denning DW; Griffiths CE
Clin Exp Dermatol; 2001 Nov; 26(8):648-53. PubMed ID: 11722447
[TBL] [Abstract][Full Text] [Related]
32. Voriconazole treatment for less-common, emerging, or refractory fungal infections.
Perfect JR; Marr KA; Walsh TJ; Greenberg RN; DuPont B; de la Torre-Cisneros J; Just-Nübling G; Schlamm HT; Lutsar I; Espinel-Ingroff A; Johnson E
Clin Infect Dis; 2003 May; 36(9):1122-31. PubMed ID: 12715306
[TBL] [Abstract][Full Text] [Related]
33. Persistent photopsia following course of oral voriconazole.
Kadikoy H; Barkmeier A; Peck B; Carvounis PE
J Ocul Pharmacol Ther; 2010 Aug; 26(4):387-8. PubMed ID: 20653481
[TBL] [Abstract][Full Text] [Related]
34. Idiosyncratic nature of voriconazole photosensitivity in children undergoing cancer therapy.
Hansford JR; Cole C; Blyth CC; Gottardo NG
J Antimicrob Chemother; 2012 Jul; 67(7):1807-9. PubMed ID: 22454488
[No Abstract] [Full Text] [Related]
35. Increased incidence of cutaneous squamous cell carcinoma in lung transplant recipients taking long-term voriconazole.
Feist A; Lee R; Osborne S; Lane J; Yung G
J Heart Lung Transplant; 2012 Nov; 31(11):1177-81. PubMed ID: 22841559
[TBL] [Abstract][Full Text] [Related]
36. Voriconazole. UK 109496.
Drugs R D; 1999 Feb; 1(2):187-8. PubMed ID: 10566023
[No Abstract] [Full Text] [Related]
37. Effect of voriconazole on the pharmacokinetics of cyclosporine in renal transplant patients.
Romero AJ; Le Pogamp P; Nilsson LG; Wood N
Clin Pharmacol Ther; 2002 Apr; 71(4):226-34. PubMed ID: 11956505
[TBL] [Abstract][Full Text] [Related]
38. Voriconazole hepatotoxicity in severe liver dysfunction.
Solís-Muñoz P; López JC; Bernal W; Willars C; Verma A; Heneghan MA; Wendon J; Auzinger G
J Infect; 2013 Jan; 66(1):80-6. PubMed ID: 23041040
[TBL] [Abstract][Full Text] [Related]
39. Drug interaction between voriconazole and calcineurin inhibitors in allogeneic hematopoietic stem cell transplant recipients.
Mori T; Aisa Y; Kato J; Nakamura Y; Ikeda Y; Okamoto S
Bone Marrow Transplant; 2009 Sep; 44(6):371-4. PubMed ID: 19270729
[TBL] [Abstract][Full Text] [Related]
40. Voriconazole versus a regimen of amphotericin B followed by fluconazole for candidaemia in non-neutropenic patients: a randomised non-inferiority trial.
Kullberg BJ; Sobel JD; Ruhnke M; Pappas PG; Viscoli C; Rex JH; Cleary JD; Rubinstein E; Church LW; Brown JM; Schlamm HT; Oborska IT; Hilton F; Hodges MR
Lancet; 2005 Oct 22-28; 366(9495):1435-42. PubMed ID: 16243088
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
